Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigenetics.

Bioinformation · 2007 · PMC2139995 · PMID 18084641

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, the data showed a trend toward an increase in CD3+Dr+ in patients with sDAT (mean ± SD; Slow Progression sDAT entry: 10.75 ± 4.95; 18 month: 14.13 ± 5.87, p = ns; Fast Progression sDAT entry: 13.10 ±7.89; 18 month: 16.40 ± 9.50, p=ns).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.